US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

ICON Public Limited Company

us-stock
To Invest in {{usstockname}}
us-stock
$187.09 0.0253(2.53%) ICLR at 04 Dec 2025 04:34 PM Diagnostics & Research
Lowest Today 181.61
Highest Today 191.08
Today’s Open 181.61
Prev. Close 183.14
52 Week High 228.29
52 Week Low 125.10
Day’s Range: Low 181.61 High 191.08
52-Week Range: Low 125.10 High 228.29
1 day return -
1 Week return +1.41
1 month return +15.08
3 month return +6.41
6 month return +34.35
1 year return -12.38
3 year return -8.31
5 year return -6.34
10 year return -

Institutional Holdings

Artisan Partners Limited Partnership 9.24

Artisan International Value 6.90

Artisan International Value Investor 6.90

Massachusetts Financial Services Company 4.82

Wellington Management Company LLP 4.71

Amvescap Plc. 3.97

Ninety One UK Limited 3.85

D. E. Shaw & Co LP 3.13

Franklin Resources Inc 2.62

FMR Inc 2.53

Citadel Advisors Llc 2.50

Ruane, Cunniff & Goldfarb L.P. 2.20

Harris Associates L.P. 2.11

AllianceBernstein L.P. 1.70

Ninety One Global Franchise 1.60

Ninety One GSF Glb Frchs I Acc USD 1.60

T. Rowe Price Associates, Inc. 1.53

1832 Asset Management L.P 1.48

ClearBridge Advisors, LLC 1.48

NORGES BANK 1.40

Comgest Global Investors SAS 1.37

Allspring Global Investments Holdings, LLC 1.36

UBS Group AG 1.26

First Pacific Advisors, LP 1.24

Principal International Eq Fd - Gross 1.19

Vanguard Windsor Investor Shares 1.15

Allspring Special Mid Cap Value Inst 1.14

Allspring Mid Value SMA 1.11

Allspring Special US Mid Cap Value Eq 1.11

T. Rowe Price US All-Cap Opp Eq Comp 1.03

Invesco Small Cap Value A 0.92

Oakmark Select Investor 0.89

Templeton Growth A 0.84

Baron Opp. Small Cap Growth Strategy 0.84

Baron Small Cap Retail 0.84

Fiduciary Mgt of Milwaukee Intl Comp 0.82

FMI International Investor 0.82

Sequoia 0.81

Templeton Growth (Euro) I(acc)EUR 0.80

Fidelity Low-Priced Stock 0.76

Market Status

Strong Buy: 11

Buy: 0

Hold: 6

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 14243.19 M

PB Ratio 1.5133

PE Ratio 24.6819

Enterprise Value 17191.12 M

Total Assets 16877.68 M

Volume 1031248

Company Financials

Annual Revenue FY24:8281675999 8281.7M, FY23:8015930000 8015.9M, FY22:7741386000 7741.4M, FY21:5480826000 5480.8M, FY20:2797288000 2797.3M

Annual Profit FY24:2436356999 2436.4M, FY23:2361029000 2361.0M, FY22:2214341000 2214.3M, FY21:1508214000 1508.2M, FY20:808032000 808.0M

Annual Net worth FY24:791474000 791.5M, FY23:513362000 513.4M, FY22:506285000 506.3M, FY21:153185000 153.2M, FY20:330792000 330.8M

Quarterly Revenue Q3/2025:2042812000 2042.8M, Q2/2025:2017357000 2017.4M, Q1/2025:2001332000 2001.3M, Q4/2024:2041101000 2041.1M, Q3/2024:2030030000 2030.0M

Quarterly Profit Q3/2025:455953000 456.0M, Q2/2025:561599000 561.6M, Q1/2025:558653000 558.7M, Q4/2024:599365000 599.4M, Q3/2024:591414000 591.4M

Quarterly Net worth Q3/2025:2355000 2.4M, Q2/2025:182972000 183.0M, Q1/2025:154151000 154.2M, Q4/2024:259998000 260.0M, Q3/2024:197128000 197.1M

Fund house & investment objective

Company Information ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.

Organisation Diagnostics & Research

Employees 39800

Industry Diagnostics & Research

CEO Mr. Barry Balfe

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right